Current Business Affairs Global Womens Health Market 2018

Global Women’s Health Market Trends, Analysis, and Forecast To 2025
Market Definition:
Women and men share various similar health problems, but women have their own health issues which needs special
attention. Women’s lives have changed over century and was more difficult. Most women did not live long enough due
to their numerous dangers and diseases. Women's health differs from that of men in several distinctive ways, owing to
various social, biological, and behavioral circumstances. Women's health refers to their reproductive health, such as
maternal health, sexual health, infertility, child marriage, menstrual cycle and other issues, and non-reproductive health
such as cardiovascular disease, cancer, mental health, anemia & violence. Women’s health is broadly affected by various
socio-cultural factors such as employment, poverty, and family responsibilities and biological factors.
Global efforts for women health improvement in the past, have majorly focused on decreasing unsatisfactorily level of
morbidity and maternal mortality. These efforts have brought a rapid decline in women’s diseases leading to the
foremost causes of women’s disability & deaths in almost all countries are now non-communicable diseases.
Although, there are various similarities in the women health issues around the world but few striking differences are
majorly due to the varied conditions in high and low income countries. Women health in these countries is critically
affected by various socio-economic factors, such as access to education, household wealth and place of residences.
Major Key Players:
Several prominent players in the women’s health market are Allergan, Agile Therapeutics, Amgen, Inc., AstraZeneca,
Bristol-Myers Squibb Company, Bayer AG, Merck & Co., Inc., Ferring B.V., Pfizer, Inc., and Teva Pharmaceutical Industries
Ltd. These companies are engaged in R&D collaboration, product portfolios expansion, and regional development in
order to increase their market share. Also, investments made by players for new product entries will spur the global
market.
Get PDF with Latest Advancement at https://www.xpodenceresearch.com/Request-Sample/105836
Market Analysis with Latest Growth Factors:
Growing female geriatric population, favorable government policies, various initiatives by private organizations with the
introduction of new medicines for women and unhealthy lifestyles of women are few of the factors responsible for
market growth. Additionally, escalation in public-private funding and endowments for infertility treatment due to high
costs associated, are projected to spur the global women health market.
As per International Osteoporosis Foundation (IOF), worldwide prevalence of osteoporosis amongst women was over
200.0 million in 1990, and has been projected to reach 680.0 million by 2050. Moreover, women are more prone to